nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenbufen—Balsalazide—Crohn's disease	0.422	1	CrCtD
Fenbufen—PTGS2—Crohn's disease	0.125	1	CbGaD
Fenbufen—Balsalazide—Sulfasalazine—Crohn's disease	0.0823	0.363	CrCrCtD
Fenbufen—Aminohippurate—Balsalazide—Crohn's disease	0.0721	0.318	CrCrCtD
Fenbufen—Bromfenac—Balsalazide—Crohn's disease	0.0721	0.318	CrCrCtD
Fenbufen—PTGS2—Balsalazide—Crohn's disease	0.0538	0.241	CbGbCtD
Fenbufen—PTGS1—Balsalazide—Crohn's disease	0.0454	0.204	CbGbCtD
Fenbufen—PTGS2—Mesalazine—Crohn's disease	0.043	0.193	CbGbCtD
Fenbufen—PTGS1—Mesalazine—Crohn's disease	0.0363	0.163	CbGbCtD
Fenbufen—PTGS2—Sulfasalazine—Crohn's disease	0.024	0.108	CbGbCtD
Fenbufen—PTGS1—Sulfasalazine—Crohn's disease	0.0203	0.0911	CbGbCtD
Fenbufen—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX4—Crohn's disease	0.000229	0.137	CbGpPWpGaD
Fenbufen—Tolmetin—CXCL8—Crohn's disease	0.000214	0.127	CrCbGaD
Fenbufen—Aminohippurate—SLC22A4—Crohn's disease	0.000177	0.105	CrCbGaD
Fenbufen—Tolmetin—MPO—Crohn's disease	0.000166	0.0985	CrCbGaD
Fenbufen—Aminohippurate—SLC22A5—Crohn's disease	0.000133	0.0788	CrCbGaD
Fenbufen—PTGS2—Calcium signaling in the CD4+ TCR pathway—CREM—Crohn's disease	0.000104	0.0628	CbGpPWpGaD
Fenbufen—Ketoprofen—CXCL8—Crohn's disease	0.000104	0.0617	CrCbGaD
Fenbufen—Ketorolac—PTGS2—Crohn's disease	9.67e-05	0.0573	CrCbGaD
Fenbufen—Bromfenac—PTGS2—Crohn's disease	9.27e-05	0.0549	CrCbGaD
Fenbufen—Balsalazide—PTGS2—Crohn's disease	8.62e-05	0.0511	CrCbGaD
Fenbufen—Tiaprofenic acid—PTGS2—Crohn's disease	7.88e-05	0.0467	CrCbGaD
Fenbufen—Nepafenac—PTGS2—Crohn's disease	7.5e-05	0.0444	CrCbGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	7.39e-05	0.0444	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	6.76e-05	0.0406	CbGpPWpGaD
Fenbufen—Oxaprozin—PTGS2—Crohn's disease	6.23e-05	0.0369	CrCbGaD
Fenbufen—Tolmetin—PTGS2—Crohn's disease	6.23e-05	0.0369	CrCbGaD
Fenbufen—Salsalate—PTGS2—Crohn's disease	6.23e-05	0.0369	CrCbGaD
Fenbufen—Suprofen—PTGS2—Crohn's disease	5.97e-05	0.0354	CrCbGaD
Fenbufen—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	5.66e-05	0.034	CbGpPWpGaD
Fenbufen—PTGS1—Arachidonic acid metabolism—GPX4—Crohn's disease	5.28e-05	0.0317	CbGpPWpGaD
Fenbufen—Fenoprofen—PTGS2—Crohn's disease	5.15e-05	0.0305	CrCbGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—CRP—Crohn's disease	4.59e-05	0.0276	CbGpPWpGaD
Fenbufen—Fenoprofen—ALB—Crohn's disease	4.59e-05	0.0272	CrCbGaD
Fenbufen—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	4.49e-05	0.027	CbGpPWpGaD
Fenbufen—PTGS2—Arachidonic acid metabolism—GPX4—Crohn's disease	4.19e-05	0.0252	CbGpPWpGaD
Fenbufen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—Crohn's disease	3.93e-05	0.0236	CbGpPWpGaD
Fenbufen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	3.93e-05	0.0236	CbGpPWpGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—CRP—Crohn's disease	3.65e-05	0.0219	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	3.36e-05	0.0202	CbGpPWpGaD
Fenbufen—Flurbiprofen—PTGS2—Crohn's disease	3.36e-05	0.0199	CrCbGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	3.08e-05	0.0185	CbGpPWpGaD
Fenbufen—Ketoprofen—PTGS2—Crohn's disease	3.04e-05	0.018	CrCbGaD
Fenbufen—Flurbiprofen—ALB—Crohn's disease	2.99e-05	0.0177	CrCbGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	2.99e-05	0.0179	CbGpPWpGaD
Fenbufen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	2.76e-05	0.0166	CbGpPWpGaD
Fenbufen—Ketoprofen—ALB—Crohn's disease	2.71e-05	0.016	CrCbGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	2.67e-05	0.016	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	2.56e-05	0.0154	CbGpPWpGaD
Fenbufen—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	2.55e-05	0.0153	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	2.54e-05	0.0153	CbGpPWpGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	2.37e-05	0.0142	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	2.15e-05	0.0129	CbGpPWpGaD
Fenbufen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	2.14e-05	0.0128	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	2.11e-05	0.0127	CbGpPWpGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	2.08e-05	0.0125	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	2.03e-05	0.0122	CbGpPWpGaD
Fenbufen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	1.82e-05	0.0109	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	1.78e-05	0.0107	CbGpPWpGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	1.68e-05	0.0101	CbGpPWpGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	1.65e-05	0.00991	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	1.59e-05	0.00955	CbGpPWpGaD
Fenbufen—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.42e-05	0.00853	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	1.35e-05	0.00809	CbGpPWpGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	1.33e-05	0.008	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.24e-05	0.00744	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.22e-05	0.00731	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	1.18e-05	0.00706	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	1.09e-05	0.00657	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	1.07e-05	0.00642	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.03e-05	0.00621	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	1.03e-05	0.0062	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	9.83e-06	0.00591	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.66e-06	0.0058	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	9.42e-06	0.00566	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	9.03e-06	0.00543	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	8.71e-06	0.00523	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	8.4e-06	0.00505	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.21e-06	0.00493	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	8.2e-06	0.00492	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	8.13e-06	0.00489	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	8.11e-06	0.00487	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.06e-06	0.00484	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	7.77e-06	0.00467	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	7.61e-06	0.00457	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.55e-06	0.00453	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	7.5e-06	0.0045	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	7.48e-06	0.00449	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	6.67e-06	0.00401	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.4e-06	0.00384	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	6.1e-06	0.00366	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.99e-06	0.0036	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	5.91e-06	0.00355	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	5.5e-06	0.0033	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PLA2G4F—Crohn's disease	5.42e-06	0.00325	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	5.28e-06	0.00317	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	4.92e-06	0.00296	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	4.84e-06	0.00291	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—MTMR3—Crohn's disease	4.61e-06	0.00277	CbGpPWpGaD
Fenbufen—PTGS2—Disease—RSPO3—Crohn's disease	4.49e-06	0.0027	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—PLA2G4F—Crohn's disease	4.3e-06	0.00258	CbGpPWpGaD
Fenbufen—PTGS2—Disease—SEL1L—Crohn's disease	4.26e-06	0.00256	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	3.91e-06	0.00235	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	3.83e-06	0.0023	CbGpPWpGaD
Fenbufen—PTGS2—Disease—LTF—Crohn's disease	3.82e-06	0.00229	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—MTMR3—Crohn's disease	3.66e-06	0.0022	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—FADS1—Crohn's disease	3.59e-06	0.00216	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—GPX4—Crohn's disease	3.36e-06	0.00202	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—GCKR—Crohn's disease	3.25e-06	0.00195	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	3.09e-06	0.00186	CbGpPWpGaD
Fenbufen—PTGS2—Disease—GCKR—Crohn's disease	3.08e-06	0.00185	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—FADS1—Crohn's disease	2.85e-06	0.00171	CbGpPWpGaD
Fenbufen—PTGS2—Disease—SLC11A1—Crohn's disease	2.72e-06	0.00163	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—GPX4—Crohn's disease	2.67e-06	0.0016	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.6e-06	0.00156	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—GCKR—Crohn's disease	2.58e-06	0.00155	CbGpPWpGaD
Fenbufen—PTGS2—Disease—HSPA1B—Crohn's disease	2.33e-06	0.0014	CbGpPWpGaD
Fenbufen—PTGS2—Disease—RBX1—Crohn's disease	2.33e-06	0.0014	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.32e-06	0.00139	CbGpPWpGaD
Fenbufen—PTGS2—Disease—UBE2D1—Crohn's disease	2.04e-06	0.00123	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.03e-06	0.00122	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.84e-06	0.00111	CbGpPWpGaD
Fenbufen—PTGS2—Disease—SMAD3—Crohn's disease	1.46e-06	0.000879	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—ALB—Crohn's disease	1.03e-06	0.000621	CbGpPWpGaD
Fenbufen—PTGS2—Disease—TYK2—Crohn's disease	9.54e-07	0.000573	CbGpPWpGaD
Fenbufen—PTGS2—Disease—JAK2—Crohn's disease	9.1e-07	0.000547	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PTGS2—Crohn's disease	9.04e-07	0.000543	CbGpPWpGaD
Fenbufen—PTGS2—Disease—CD4—Crohn's disease	8.63e-07	0.000518	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—ALB—Crohn's disease	8.2e-07	0.000493	CbGpPWpGaD
Fenbufen—PTGS2—Disease—STAT3—Crohn's disease	6.68e-07	0.000401	CbGpPWpGaD
Fenbufen—PTGS2—Disease—IL6—Crohn's disease	4.67e-07	0.00028	CbGpPWpGaD
